Your browser doesn't support javascript.
loading
Amyloid-like p53 as prognostic biomarker in serous ovarian cancer-a study of the OVCAD consortium.
Heinzl, Nicole; Maritschnegg, Elisabeth; Koziel, Katarzyna; Schilhart-Wallisch, Christine; Heinze, Georg; Yang, Wei-Lei; Bast, Robert C; Sehouli, Jalid; Braicu, Elena I; Vergote, Ignace; Van Gorp, Toon; Mahner, Sven; Paspalj, Valentina; Grimm, Christoph; Obermayr, Eva; Schuster, Eva; Holzer, Barbara; Rousseau, Frederic; Schymkowitz, Joost; Concin, Nicole; Zeillinger, Robert.
Afiliación
  • Heinzl N; Department of Obstetrics and Gynaecology, Molecular Oncology Group, Comprehensive Cancer Center-Gynaecologic Cancer Unit, Medical University of Vienna, Vienna, Austria.
  • Maritschnegg E; Department of Obstetrics and Gynaecology, Molecular Oncology Group, Comprehensive Cancer Center-Gynaecologic Cancer Unit, Medical University of Vienna, Vienna, Austria.
  • Koziel K; Switch Laboratory, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.
  • Schilhart-Wallisch C; Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, Box 802, 3000, Leuven, Belgium.
  • Heinze G; Department of Gynaecology and Obstetrics, Innsbruck Medical University, Innsbruck, Austria.
  • Yang WL; Section for Clinical Biometrics, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
  • Bast RC; Section for Clinical Biometrics, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
  • Sehouli J; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Braicu EI; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
  • Vergote I; Department of Gynaecology, European Competence Center for Ovarian Cancer, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Virchow Klinikum, Berlin, Germany.
  • Van Gorp T; Department of Gynaecology, European Competence Center for Ovarian Cancer, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Virchow Klinikum, Berlin, Germany.
  • Mahner S; Department of Obstetrics and Gynecology, Stanford University, Stanford, CA, USA.
  • Paspalj V; Division of Gynaecologic Oncology, University Hospital Leuven, Leuven, Belgium.
  • Grimm C; Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
  • Obermayr E; Division of Gynaecologic Oncology, University Hospital Leuven, Leuven, Belgium.
  • Schuster E; Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
  • Holzer B; Department of Gynaecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Rousseau F; Department of Obstetrics and Gynaecology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Schymkowitz J; Department of Obstetrics and Gynaecology, Division of General Gynaecology and Gynaecologic Oncology, Comprehensive Cancer Center-Gynaecologic Cancer Unit, Medical University of Vienna, Vienna, Austria.
  • Concin N; Department of Obstetrics and Gynaecology, Division of General Gynaecology and Gynaecologic Oncology, Comprehensive Cancer Center-Gynaecologic Cancer Unit, Medical University of Vienna, Vienna, Austria.
  • Zeillinger R; Department of Obstetrics and Gynaecology, Molecular Oncology Group, Comprehensive Cancer Center-Gynaecologic Cancer Unit, Medical University of Vienna, Vienna, Austria.
Oncogene ; 42(33): 2473-2484, 2023 08.
Article en En | MEDLINE | ID: mdl-37402882
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Cistadenocarcinoma Seroso Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Cistadenocarcinoma Seroso Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Austria